CMS released its calendar year 2025 Medicare Physician Fee Schedule Final Rule on Nov. 1, including a new add-on code for infectious diseases developed and advocated for by IDSA.
Thank you @CMSgov for including this code and supporting the ID workforce.
https://t.co/g4n9TPTSYA
Learn how to use new G2211 code introduced in the 2024 evaluation and management services revisions by CMS in our new webinar feat. Timothy Sullivan, MD, FIDSA (@TimSullivanMD), and John Fangman, MD. https://t.co/SxhodP4CZG
Dr. Timothy Sullivan discusses why people are getting infected with Vibrio vulnificus, a “flesh-eating bacteria,” in New York City, how to prevent it, and what to do if you’ve been infected: https://t.co/X6AoQhqT1j
@jschaenman@AST_IDCOP@TxID_Fellows Would give mold-active antifungal PPX (isavuconazole) at the time of transplant but would not start treatment now without evidence of active infection.
@ShohamTxID I agree! For a reference on this, critical care billing is included in the 2023 IDSA E/M guide and discussed in the 2023 E/M webinar, both available here:
https://t.co/FFEXSDWZu1
@okwalding Given our issues with relatively low compensation in ID, I wouldn’t delay finding an attending position by another year if you’ve had significant TxID exposure during a 2-year fellowship.
@abronsonabx This survey included few ID physicians, so it’s probably not a very representative sample.
Concerns about compensation are real, but ID is likely a happier specialty than this. It’s also an endlessly fascinating, challenging and rewarding field, if you’re still on the fence!
"We should be investing in fortifying our health care system so that, when the next pandemic arrives, frontline workers won’t need to become heroes," says IDSA member Timothy Sullivan, MD, FIDSA in a new op-ed published in @thehill. https://t.co/0xN2QHu4FW
Reducing cancer and opioid deaths will only be possible with a strong infectious diseases workforce coupled with federal investments, says IDSA President @CarlosdelRio7 in response to @POTUS's 2023 health priorities.
Our statement: https://t.co/yeZkdp7UUv #ValueofID#SOTU2023
Happy to share our experience treating Tuberculosis without use of rifampin in transplanted patients. We believe that the paradigm of rifampin should be challenged in patients with risk of cumbersome PK interactions. https://t.co/oJKvqSThQy
Just 56% of ID fellowship programs filled all of their open positions this year.
"It's very unusual for us not to fill," said @Armstrws of @EmoryDeptofMed. "Far too many programs, including long-established programs, were in a similar boat."
https://t.co/RvcHHwB0uD #MATCH2023
@EricTopol I agree, thanks for highlighting this important issue. I think the cost of adopting this technology could be more than offset by the savings on decreased length of hospitalization and less need for other expensive tests.
AI-generated clinical documentation may be a huge time-saver for ID physicians (and others) in the future
#ChatGPT already generates decent ID consult notes from simple prompts
#IDTwitter
In this study by @TimSullivanMD, Twitter data, natural language processing and deep learning were used to identify and map outpatient antibiotic misuse in the United States. #antibioticstewardship#AntimicrobialResistance
https://t.co/deWBXBEEXg